Target Name: Nicalin-NOMO complex
NCBI ID: P18955
Review Report on Nicalin-NOMO complex Target / Biomarker Content of Review Report on Nicalin-NOMO complex Target / Biomarker
Nicalin-NOMO complex
Other Name(s): None

The Nicalin-NOMO Complex: A Protein Regulator of Cell Signaling Pathways

The Nicalin-NOMO complex is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is made up of four subunits: Nicalin, NOMO-1, NOMO-2, and NOMO-3.

Nicalin is a small protein that is involved in the regulation of cell signaling pathways. It is a negative regulator of the protein kinase A, which is a key enzyme involved in cell signaling. In addition to its role in signaling pathways, nicalin is also involved in the regulation of inflammation and cellular stress.

NOMO-1, NOMO-2, and NOMO-3 are all involved in the regulation of cell signaling pathways. NOMO-1 and NOMO-2 are negative regulators of the protein kinase B, which is involved in cell signaling pathways. NOMO-3 is a negative regulator of the protein kinase C, which is involved in cell signaling pathways.

The Nicalin-NOMO complex is thought to play a role in the regulation of various physiological processes in the body, including cell signaling pathways, inflammation, and cellular stress. It is also involved in the regulation of the immune system, as well as the regulation of the blood pressure.

One potential drug target for the Nicalin-NOMO complex is the inhibition of the protein kinase B. This can be achieved through the use of small molecules, such as inhibitors of the B-type calcium channel. By inhibiting the B-type calcium channel, it is thought that the Nicalin-NOMO complex may be able to regulate the activity of the protein kinase B, which could potentially lead to the inhibition of cell signaling pathways.

Another potential drug target for the Nicalin-NOMO complex is the inhibition of the protein kinase C. This can be achieved through the use of small molecules, such as inhibitors of the C-type zinc finger protein. By inhibiting the C-type zinc finger protein, it is thought that the Nicalin-NOMO complex may be able to regulate the activity of the protein kinase C, which could potentially lead to the inhibition of cell signaling pathways.

Overall, the Nicalin-NOMO complex is a protein that is involved in the regulation of various physiological processes in the body. It is also thought to play a role in the regulation of cell signaling pathways, inflammation, and cellular stress. The inhibition of the protein kinase B and C could potentially lead to the inhibition of cell signaling pathways, making the Nicalin-NOMO complex a potential drug target.

Protein Name: Nicalin-NOMO Complex

The "Nicalin-NOMO complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Nicalin-NOMO complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NICN1 | Nicotinic (alpha4beta2)2alpha4 receptor | Nicotinic (alpha4beta2)2beta2 receptor | Nicotinic alpha1beta1deltaepsilon Receptor | Nicotinic alpha1beta1deltagamma Receptor | Nicotinic alpha3alpha6beta2 Receptor | Nicotinic alpha3beta2 receptor | Nicotinic alpha3beta2beta3 receptor | Nicotinic alpha3beta4 Receptor | Nicotinic alpha4beta2 receptor | Nicotinic alpha4beta2alpha5 Receptor | Nicotinic alpha4beta4 receptor | Nicotinic alpha6alpha3beta2 Receptor | Nicotinic alpha6alpha3beta2beta3 receptor | Nicotinic alpha6beta2alpha4beta2beta3 receptor | Nicotinic alpha6beta2beta3 receptor | Nicotinic alpha6beta4beta3alpha5 receptor | Nicotinic alpha9alpha10 Receptor | NID1 | NID2 | NIF3L1 | NIFK | NIFK-AS1 | NIHCOLE | NIM1K | NIN | NINJ1 | NINJ2 | NINJ2-AS1 | NINL | NIP7 | NIPA1 | NIPA2 | NIPAL1 | NIPAL2 | NIPAL3 | NIPAL4 | NIPBL | NIPBL-DT | NIPSNAP1 | NIPSNAP2 | NIPSNAP3A | NIPSNAP3B | NISCH | NIT1 | NIT2 | Nitric oxide synthase (NOS) | NKAIN1 | NKAIN1P1 | NKAIN2 | NKAIN3 | NKAIN4 | NKAP | NKAPD1 | NKAPL | NKAPP1 | NKD1 | NKD2 | NKG7 | NKILA | NKIRAS1 | NKIRAS2 | NKPD1 | NKRF | NKTR | NKX1-1 | NKX1-2 | NKX2-1 | NKX2-1-AS1 | NKX2-2 | NKX2-3 | NKX2-4 | NKX2-5 | NKX2-6 | NKX2-8 | NKX3-1 | NKX3-2 | NKX6-1 | NKX6-2 | NKX6-3 | NLE1 | NLGN1 | NLGN1-AS1 | NLGN2 | NLGN3 | NLGN4X | NLGN4Y | NLK | NLN | NLRC3 | NLRC4 | NLRC4 Inflammasome | NLRC5 | NLRP1 | NLRP1 Inflammasome | NLRP10 | NLRP11 | NLRP12 | NLRP13 | NLRP14